Profile cover photo
Profile photo
Arik Fetscher
All videos on Youtube were done entirely from the research through questions to all organizing. like a producer or editor in journalism would do.
All videos on Youtube were done entirely from the research through questions to all organizing. like a producer or editor in journalism would do.

Arik's posts

Post has shared content
Maybe maybe not but it does owe the EU a lot for the way ECB, Breton Woods and Euro set up to finance German Unification and benefit the German bond market and borrowing along with its export markets. So I bit of an Economic NATO argument that both France and the US could make and simply welcoming cheaper labor to repeat the process is not enough Germany needs to be more like France now and not make the mistake of Japan in early 90s nor keep its currency low via Greece and E Europe while ECB cannt issue bonds to finance less developed economies. This is some Nobel level economics going on at a macro-economic political level.

Arik Fetscher

Post has shared content
I don't know but with victim lawsuits and the EU investigations and legislation this move by Facebook might not just qualify as incredibly dumb and short sighted but also a smoking gun for legal claims. If they can delete and block a blog that is merely critical then where are they on the hate speech and incitement to violence for which the Israeli government even questioned the company? Then the "fake news" issue and the questions about how it's also returns results it would seem there are some real issues starting to come to the surface.

Arik Fetscher

PS when you invest in a company, which users do by creating the content for a social media company, you better know and believe in the ones running that company because if they are bad; that bad business will eventually affect results and viability.

Post has shared content
It tends to happen that way. All those liberal loves like peace and equality start with what they appreciate the least the military where discipline is in grained by necessity.

Maybe the Kurds & UAE with Maj. Mariam actually understand more than given credit. 

Post has shared content

Hi Devils... I challenge you...! 😎
What are these legends'/players' names?
Come on... No rewards,



Post has shared content

Post has shared content

Post has shared content
The utility reforms are a real key and a way pro-renewable folks can get market de-regulation conservative types on board by requiring opening up utility markets in the US FERC is a major choke point on renewable integration and use. Along with the cyber security issue of more modern smart grids and upgraded transmission lines.

Post has attachment
I'm going to watch SheBelieves Cup - France vs. Germany Today at 2:15p ET on FOX Sports GO

Post has shared content
#Gene therapy ‘cures’ boy of blood disease that affects millions - So far, gene therapy has only treated rare disorders. Now, for the first time, it has been used to treat a boy with sickle cell disease, a common genetic disease
TEENAGE boy with an inherited disease that affects millions worldwide seems to have been cured using gene therapy. The treatment appears to have stopped the painful symptoms of sickle cell disease, demonstrating the potential for gene therapy to treat common genetic diseases.
The idea of gene therapy – using strands of DNA to compensate for a person’s malfunctioning genes – is almost three decades old. However, the approach has so far mostly been used to treat very rare diseases (see “Long road to success“). In contrast, sickle cell disease affects 100,000 people in the US alone. If the treatment proves successful in larger trials, it could bring gene therapy into widespread use.

“It could be a game changer,” says Deborah Gill at the University of Oxford. “The fact the team has a patient with real clinical benefit, and biological markers to prove it, is a very big deal.”

People with sickle cell disease make abnormal versions of haemoglobin, the blood protein that carries oxygen around the body. This can be caused by mutations in the gene that makes a subunit of haemoglobin, called beta-globin. The mutations cause haemoglobin to clump together, distorting red blood cells into a sickle-shape that can get stuck in blood vessels around the body.

People with the disorder are given blood transfusions to clear these painful blockages and prevent new ones. Bone marrow transplants can treat the disease, but matching donors can only be found for around 10 per cent of people with the condition.

Now a team in France seems to have developed a treatment that would work for everyone with the disorder. First, the team took bone marrow stem cells from the boy when he was 13, and gave them extra, mutated versions of the gene that codes for beta-globin. These were designed to make beta-globin that would interfere with the boy’s faulty proteins, stopping them from clumping together.

>>>> The researchers then put these stem cells back into the boy’s body. After around three months, he began producing large quantities of haemoglobin that behaves normally. “The patient is now 15 years old and free of all previous medication,” says Marina Cavazzana at the Necker Children’s Hospital in Paris, who led the team. “He has been free of pain from blood vessel blockages, and has given up taking opioid painkillers.”

Cavazzana is confident these benefits will last. “All the tests we performed on his blood show that he’s been cured, but more certainty can only come from long-term follow-up.” She says her team has treated seven other patients, who are showing “promising” progress.

“We are all very excited by the work, and this success provides support for this and other genetic strategies targeting this horrible disease,” says John Tisdale at the US National Heart, Lung, and Blood Institute in Maryland.

David Williams, at Boston Children’s Hospital in Massachusetts, suggests that the boy may still occasionally experience blockages, because his own original genes are still able to produce faulty haemoglobin. “It’s important to see what happens over time, and how many other patients see similar benefits.”

However, should the gene therapy prove to be effective in larger trials, its expense may limit its use to richer nations. “We should be realistic in remembering that there are hundreds of thousands of sickle cell patients in less developed countries, and that the therapy is not easily exportable or adaptable to countries with less well-developed health systems,” says Stuart Orkin at Harvard Medical School.

Long road to success

Twenty years ago, gene therapy was touted as a cure for everything from cancer to cystic fibrosis. Now it is finally starting to fulfil its promise.

In 2012, Glybera became the first gene therapy to be approved, for people with a rare disorder that makes them unable to process dietary fat. Last year, the first commercial gene therapy that alters a person’s DNA was approved for children with a severe immune disorder. Gene therapies for rare forms of blindness are also showing promise.

But these conditions all affect very small numbers of people. Research into sickle cell disease (see main story), beta thalassaemia, haemophilia and cystic fibrosis mean gene therapy may not be too far from becoming mainstream medicine for the most common genetic diseases.
article source and all credicts :
Wait while more posts are being loaded